Symbols / CABR Stock $1.17 -2.50% Caring Brands, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NCM
CABR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Dr. Glynn Wilson Ph.D.
Exch · Country NCM · United States
Market Cap 10.64M
Enterprise Value 12.67M
Income -9.59M
Sales 2.75K
FCF (ttm) —
Book/sh -0.23
Cash/sh 0.22
Employees 3
Insider 10d —
IPO Nov 17, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 3,873.66
P/B -5.18
P/C —
EV/EBITDA -2.97
EV/Sales 4,612.47
Quick Ratio 5.29
Current Ratio 5.65
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -0.69
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE -282.84%
ROIC —
Gross Margin 56.48%
Oper. Margin -1,663.21%
Profit Margin 0.00%
Shs Outstand 9.09M
Shs Float 1.54M
Insider Own 89.09%
Instit Own 2.26%
Short Float 0.27%
Short Ratio 0.22
Short Interest 20.80K
52W High 1.65
vs 52W High -29.09%
52W Low 0.71
vs 52W Low 64.79%
Beta —
Impl. Vol. —
Rel Volume 1.03
Avg Volume 86.36K
Volume 88.70K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.20
Price $1.17
Change -2.50%
About

Caring Brands, Inc., a wellness consumer products company, provides over-the-counter and cosmetic consumer products. It offers Hair Enzyme Booster (JW-700) for the treatment of hair growth; Photocil for the treatment of psoriasis and vitiligo; and CB-101 (Eczema Treatment) for atopic dermatitis (eczema). The company also offers NoStingz for the protection from jellyfish, sea lice, and UVA/UVB rays; and GoldN for Ebola diagnostics, as well as provides vitiligo solutions and women's sexual wellness products. Caring Brands, Inc., was incorporated in 2020 and is based in Fort Pierce, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.17
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
$1.17
Low
—
High
—
Mean
—
News
RSS: Latest CABR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-11 WILSON GLYNN Chief Executive Officer — 172,592 $0.00 $0
2025-12-11 MOORE TYLER THOMAS Chief Financial Officer — 300,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Revenue
0.00
+806.45%
0.00
-97.72%
0.02
Operating Revenue
0.00
+806.45%
0.00
-97.72%
0.02
Cost Of Revenue
0.00
-9.60%
0.00
-98.26%
0.12
Reconciled Cost Of Revenue
0.00
-9.60%
0.00
-98.26%
0.12
Gross Profit
0.00
+245.74%
-0.00
+98.37%
-0.10
Operating Expense
3.39
+122.01%
1.53
+2782.05%
0.05
Selling General And Administration
3.09
+328.08%
0.72
—
General And Administrative Expense
3.09
—
—
Salaries And Wages
2.01
—
—
Other Gand A
1.08
—
—
Total Expenses
3.39
+121.83%
1.53
+789.25%
0.17
Operating Income
-3.39
-121.62%
-1.53
-908.89%
-0.15
Total Operating Income As Reported
-5.94
—
—
EBITDA
-3.09
-123.98%
-1.38
-823.22%
-0.15
Normalized EBITDA
-0.21
+84.75%
-1.38
-698.48%
-0.17
Reconciled Depreciation
0.30
+100.00%
0.15
+6718.18%
0.00
EBIT
-3.39
-121.62%
-1.53
-908.89%
-0.15
Total Unusual Items
-2.88
—
0.02
Total Unusual Items Excluding Goodwill
-2.88
—
0.02
Special Income Charges
-2.88
—
0.02
Other Special Charges
-0.17
—
—
Impairment Of Capital Assets
2.55
—
—
Write Off
0.50
—
—
Net Income
-6.28
-313.74%
-1.52
-1084.70%
-0.13
Pretax Income
-6.28
-313.74%
-1.52
-1084.70%
-0.13
Net Non Operating Interest Income Expense
-0.02
-292.37%
0.01
0.00
Net Interest Income
-0.02
-292.37%
0.01
0.00
Other Income Expense
-2.87
—
0.02
Other Non Operating Income Expenses
0.00
—
—
Tax Rate For Calcs
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-6.28
-313.74%
-1.52
-1084.70%
-0.13
Net Income From Continuing Operation Net Minority Interest
-6.28
-313.74%
-1.52
-1084.70%
-0.13
Net Income From Continuing And Discontinued Operation
-6.28
-313.74%
-1.52
-1084.70%
-0.13
Net Income Continuous Operations
-6.28
-313.74%
-1.52
-1084.70%
-0.13
Normalized Income
-3.40
-124.27%
-1.52
-902.31%
-0.15
Net Income Common Stockholders
-6.28
-313.74%
-1.52
-1084.70%
-0.13
Diluted EPS
-0.46
-327.74%
-0.11
-885.46%
-0.01
Basic EPS
-0.46
-327.74%
-0.11
-885.46%
-0.01
Basic Average Shares
13.57
-3.86%
14.11
+20.22%
11.74
Diluted Average Shares
13.57
-3.86%
14.11
+20.22%
11.74
Diluted NI Availto Com Stockholders
-6.28
-313.74%
-1.52
-1084.70%
-0.13
Depreciation Amortization Depletion Income Statement
0.30
—
—
Depreciation And Amortization In Income Statement
0.30
—
—
Gain On Sale Of PPE
—
—
0.02
Total Other Finance Cost
0.02
+292.37%
-0.01
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
2.33
-39.99%
3.88
+16821.15%
0.02
Current Assets
2.33
+341.12%
0.53
+2201.90%
0.02
Cash Cash Equivalents And Short Term Investments
2.19
+366.79%
0.47
+2482.45%
0.02
Cash And Cash Equivalents
2.19
+366.79%
0.47
+2482.45%
0.02
Cash Financial
2.19
+366.79%
0.47
+2482.45%
0.02
Receivables
—
0.00
-100.00%
0.00
Accounts Receivable
—
0.00
-100.00%
0.00
Inventory
0.01
-6.44%
0.01
0.00
Prepaid Assets
—
0.04
+918.05%
0.00
Other Current Assets
0.12
+178.56%
0.04
—
Total Non Current Assets
0.00
-100.00%
3.35
0.00
Goodwill And Other Intangible Assets
0.00
-100.00%
2.85
0.00
Other Intangible Assets
—
2.85
—
Investments And Advances
0.00
-100.00%
0.50
0.00
Long Term Equity Investment
0.00
-100.00%
0.50
0.00
Total Liabilities Net Minority Interest
0.24
+26.54%
0.19
-35.53%
0.29
Current Liabilities
0.18
-4.98%
0.19
+756.29%
0.02
Payables And Accrued Expenses
0.18
-4.98%
0.19
+756.29%
0.02
Payables
0.17
+0.54%
0.17
+719.90%
0.02
Accounts Payable
0.17
+0.54%
0.17
+719.90%
0.02
Current Accrued Expenses
0.01
-61.06%
0.02
+1459.68%
0.00
Total Non Current Liabilities Net Minority Interest
0.06
0.00
-100.00%
0.27
Long Term Debt And Capital Lease Obligation
0.06
—
0.27
Long Term Debt
0.06
—
0.27
Stockholders Equity
2.09
-43.35%
3.69
+1488.92%
-0.27
Common Stock Equity
2.09
-43.35%
3.69
+1488.92%
-0.27
Capital Stock
0.10
+645.73%
0.01
0.00
Common Stock
0.10
+645.73%
0.01
0.00
Preferred Stock
0.00
0.00
0.00
Share Issued
14.76
+4.62%
14.11
+0.00%
14.11
Ordinary Shares Number
14.76
+4.62%
14.11
+0.00%
14.11
Additional Paid In Capital
9.14
+101.17%
4.54
0.00
Retained Earnings
-7.14
-727.66%
-0.86
-224.63%
-0.27
Total Equity Gross Minority Interest
2.09
-43.35%
3.69
+1488.92%
-0.27
Total Capitalization
2.15
-41.76%
3.69
+312463.59%
0.00
Working Capital
2.15
+529.80%
0.34
+28805.67%
0.00
Invested Capital
2.15
-41.76%
3.69
+312463.59%
0.00
Total Debt
0.06
—
0.27
Net Debt
—
—
0.25
Net Tangible Assets
2.09
+148.56%
0.84
+416.58%
-0.27
Tangible Book Value
2.09
+148.56%
0.84
+416.58%
-0.27
Available For Sale Securities
—
0.50
—
Interest Payable
0.00
0.00
—
Investmentin Financial Assets
—
0.50
—
Other Equity Interest
-0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Operating Cash Flow
-1.69
-105.37%
-0.82
-1305.36%
-0.06
Cash Flow From Continuing Operating Activities
-1.69
-105.37%
-0.82
-1305.36%
-0.06
Net Income From Continuing Operations
-6.28
-313.74%
-1.52
-1084.70%
-0.13
Depreciation Amortization Depletion
0.30
+100.00%
0.15
+6718.18%
0.00
Depreciation
—
—
0.00
Amortization Cash Flow
—
—
0.00
Depreciation And Amortization
0.30
+100.00%
0.15
+6718.18%
0.00
Amortization Of Intangibles
—
—
0.00
Other Non Cash Items
0.01
—
—
Stock Based Compensation
1.24
+209.66%
0.40
0.00
Asset Impairment Charge
2.55
—
—
Operating Gains Losses
0.68
—
-0.02
Gain Loss On Investment Securities
0.50
—
—
Change In Working Capital
-0.18
-228.54%
0.14
+58.39%
0.09
Change In Receivables
0.00
-100.00%
0.00
+1866.67%
0.00
Changes In Account Receivables
0.00
-100.00%
0.00
+1866.67%
0.00
Change In Inventory
0.00
0.00
-100.00%
0.08
Change In Prepaid Assets
-0.08
-127.57%
-0.04
-698.82%
-0.00
Change In Payables And Accrued Expense
-0.11
-159.07%
0.18
+1200.69%
0.01
Change In Accrued Expense
-0.01
-127.25%
0.04
+845.87%
-0.01
Change In Payable
-0.10
-167.50%
0.14
+652.93%
0.02
Change In Account Payable
-0.10
-167.50%
0.14
+652.93%
0.02
Investing Cash Flow
0.00
-100.00%
0.61
+1456.51%
0.04
Cash Flow From Continuing Investing Activities
0.00
—
0.04
Net Investment Purchase And Sale
—
—
0.00
Purchase Of Investment
—
—
0.00
Net Business Purchase And Sale
0.00
—
—
Net Other Investing Changes
—
—
0.04
Financing Cash Flow
3.41
+412.21%
0.67
+4228.99%
0.02
Cash Flow From Continuing Financing Activities
3.41
+412.21%
0.67
+4228.99%
0.02
Net Issuance Payments Of Debt
0.17
-74.48%
0.67
+4228.99%
0.02
Issuance Of Debt
0.29
-56.47%
0.67
+4228.99%
0.02
Repayment Of Debt
-0.12
—
0.00
Long Term Debt Issuance
0.29
-56.47%
0.67
+4228.99%
0.02
Long Term Debt Payments
-0.12
—
—
Net Long Term Debt Issuance
0.17
-74.48%
0.67
+4228.99%
0.02
Short Term Debt Payments
—
—
0.00
Net Short Term Debt Issuance
—
—
0.00
Net Common Stock Issuance
3.24
0.00
0.00
Changes In Cash
1.72
+281.56%
0.45
+10984.52%
-0.00
Beginning Cash Position
0.47
+2482.45%
0.02
-18.57%
0.02
End Cash Position
2.19
+366.79%
0.47
+2482.45%
0.02
Free Cash Flow
-1.69
-105.37%
-0.82
-1305.36%
-0.06
Interest Paid Supplemental Data
—
—
0.00
Income Tax Paid Supplemental Data
—
—
0.00
Common Stock Issuance
3.24
0.00
0.00
Issuance Of Capital Stock
3.24
0.00
0.00
Sale Of Business
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category